Top Markets
#1 ADO Protocol ADO Protocol +193.44%
#2 Islamic Coin Islamic Coin +155.40%
#3 GoPlus Security GoPlus Security +43.47%
#4 GAIB AID GAIB AID +24.67%
#5 Verus Coin Verus Coin +13.64%
#6 SkyAI SkyAI +13.54%
#7 o1.exchange o1.exchange +12.48%
#8 Starpower Starpower +12.35%
#9 Casper Network Casper Network +12.23%
#10 Ontology Gas Ontology Gas +10.82%
Coin of the day
ADO Protocol ADO Protocol
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Classement en actions #33455
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Prix de l'action
$0.5099
Dernière synchronisation: 2024-10-15
Capitalisation boursière
$7.60M
Changement (1 jour)
2.02%
Changement (1 an)
0.00%
Pays
US
Échange Anew Medical, Inc. (WENA)

Catégorie

Healthcare
Bénéfices pour Anew Medical, Inc. (WENA)
Bénéfices en Jun 2024 TTM : $114.12K
Selon les derniers rapports financiers de Anew Medical, Inc., les bénéfices actuels de l'entreprise sont de $114.12K. En 2022, l'entreprise a réalisé un bénéfice de $1.56M, une augmentation par rapport à celui de 2021 qui était de $-1.11M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Anew Medical, Inc. de 2021 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $114.12K -94.40%
2023 $2.04M 30.95%
2022 $1.56M -240.25%
2021 $-1.11M 0.00%
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B 4,622,261.26%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B 1,709,242.25%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B 2,633,790.84%
BE